Skip to main content

Advertisement

SpringerLink
Log in

Exploring metabolic and inflammatory abnormalities in rheumatoid arthritis patients developing stroke disease: a case-control study using electronic medical record data in northern China

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objectives

Intend to investigate the roles of serum lipids, inflammatory markers, and serological status in rheumatoid arthritis and stroke patients by using case-control study.

Materials and methods

Clinical data were retrieved from the electronic medical record of the First Affiliated Hospital of China Medical University during January 2011 to March 2018. The obtained data were categorized into case groups and three control groups, in the ratios of 1:2, respectively, with all matching age and gender. Multinomial logistic regression analysis and restricted cubic spline were conducted examining the associations between serum lipids, inflammatory markers, serological status, and the risk of stroke among RA patients.

Results

The present studies included 1057 study subjects. The elevated ESR, LDL-C levels, and much higher CRP levels ≥ 230 mg/L were independent risk factors for RA patients in developing stroke. Furthermore, we found that ESR and LDL-C levels could exhibit a linear association with the risk of comorbid stroke while CRP level had a nonlinearity association with stroke risk among RA patients.

Conclusions

A close monitoring is required for RA patients with dyslipidemia and elevated inflammatory markers, and the primary stroke preventive strategies should be directed against these risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Junbo Ge YX (2013) Internal Medicine. 8 ed. People’s Medical Publishing House, BeiJing

    Google Scholar 

  2. Zhanguo Li F (2009) Rheumatoid arthritis. 1 ed: People’s Medical Publishing House

  3. Lévy LFB, Barnetche T, Schaeverbeke T (2008) Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients: a systematic review of the literature. Clin Exp Rheumatol 26:67

    Google Scholar 

  4. Wiseman SJ, Ralston SH, Wardlaw JM (2016) Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis. Stroke 47:4943–4950. https://doi.org/10.1161/strokeaha.115.012052

    Article  Google Scholar 

  5. Mackey RH, Kuller LH, Deane KD, Walitt BT, Chang YF, Holers VM et al (2015) Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the women’s health initiative. Arthritis Rheumatol 67:92311–92322. https://doi.org/10.1002/art.39198

  6. Lindhardsen J, Gislason GH, Ahlehoff O, Madsen OR, Hansen PR.(2010) Increased risk of stroke and atrial fibrillation in rheumatoid arthritis - a nationwide cohort study. Eur Heart J 31156

  7. Liou TH, Huang SW, Lin JW, Chang YS, Wu CW, Lin HW.(2014) Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study. Sci Rep.45110. doi: https://doi.org/10.1038/srep05110

  8. Navarro-Millan I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW et al (2016) Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis 75:2341–2347. https://doi.org/10.1136/annrheumdis-2013-204987

    Article  CAS  Google Scholar 

  9. Dursunoglu D, Evrengul H, Polat B, Tanriverdi H, Cobankara V, Kaftan A et al (2005) Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 25:4241–4245. https://doi.org/10.1007/s00296-004-0438-0

    Article  CAS  Google Scholar 

  10. Semb AG, Kvien TK, Aastveit AH, Jungner I, Pedersen TR, Walldius G et al (2010) Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis 69:111996–112001. https://doi.org/10.1136/ard.2009.126128

    Article  CAS  Google Scholar 

  11. Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM et al (2014) The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 73:71301–71308. https://doi.org/10.1136/annrheumdis-2013-204715

    Article  CAS  Google Scholar 

  12. Goodson NJ, Symmons DP, Scott DG (2005) Baseline levels of C reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow up study of a primary care-based inception cohort. Arthritis Rheum 52:2293–2299

    Article  CAS  PubMed  Google Scholar 

  13. Huijun Sun TK, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen YE, Fan J (2005) C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 167(4):1139–1148

    Article  PubMed  PubMed Central  Google Scholar 

  14. Arnett FC, Edworthy SM, Bloch DA (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum p. 315–24

  15. Association CN.(2013) Diagnosis of various cerebrovascular diseases(1995). J Clin Exp Med 12:71

  16. adults TjcopacoabliC (2012) Guidelines on Prevention and Treatment of Blood Lipid Abnormality in Chinese Adults. The joint committee on prevention and control of abnormal blood lipids in Chinese adults

  17. adults. TjcopacoabliC (2016) Guidelines on Prevention and Treatment of Blood Lipid Abnormality in Chinese Adults(2016 Revised). Guidelines and consensus. Chinese Circulation Journal: The joint committee on prevention and control of abnormal blood lipids in Chinese adults

  18. Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:136–140

    Google Scholar 

  19. Ku IA, Imboden JB, Hsue PY, Ganz P (2009) Rheumatoid arthritis a model of systemic inflammation driving atherosclerosis. Circ J 73:6977–6985

    Article  Google Scholar 

  20. Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F (2008) Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 59:81090–81096. https://doi.org/10.1002/art.23935

    Article  Google Scholar 

  21. Liao KP, Liu J, Lu B, Solomon DH, Kim SC (2015) Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. Arthritis Rheum 67:82004–82010. https://doi.org/10.1002/art.39165

    Article  CAS  Google Scholar 

  22. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM et al (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:3482–3487. https://doi.org/10.1136/ard.2010.135871

    Article  CAS  Google Scholar 

  23. Jurcut C, Jurcut R, Tanasescu C (2004) Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. Rom J Int Med 42:4659–4669

    Google Scholar 

  24. Combe B, Cantagrel A, Goupille P, Bozonnat MC, Sibilia J, Eliaou JF et al (2003) Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol 30:112344–112349

    Google Scholar 

  25. Guillemin F, Gerard N, van Leeuwen M, Smedstad LM, Kvien TK, van den Heuvel W (2003) Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J Rheumat 30:122585–122589

    Google Scholar 

  26. Del Rincon I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:71833–71840. https://doi.org/10.1002/art.11078

    Article  Google Scholar 

  27. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:3722–3732. https://doi.org/10.1002/art.20878

    Article  Google Scholar 

  28. Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24:291–104

    Article  Google Scholar 

  29. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:3499–3511

    Google Scholar 

  30. Hjeltnes G, Hollan I (2011) Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients. Scand J Rheumatol 40:6422–6427

    Article  CAS  Google Scholar 

  31. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K et al (2003) C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107:152016–152020. https://doi.org/10.1161/01.cir.0000065228.20100.f7

    Article  Google Scholar 

  32. Min Su TS (2011) The correlation between vascular endothelial dysfunction and serum inflammatory factors and serum lipid levels in patients with rheumatoid arthritis. Chin J Clin Lab Sci 29:4265. https://doi.org/10.13602/j.cnki.jcls.2011.04.034

  33. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695

    Article  CAS  PubMed  Google Scholar 

  34. Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed G, Tsao P et al (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 70:4576–4582. https://doi.org/10.1136/ard.2010.129916

    Article  Google Scholar 

  35. Low AS, Lunt M, Mercer LK, Watson KD, Dixon WG, Symmons DP et al (2016) Association between ischemic stroke and tumor necrosis factor inhibitor therapy in patients with rheumatoid arthritis. Arthritis Rheum 68:61337–61345. https://doi.org/10.1002/art.39582

    Article  CAS  Google Scholar 

  36. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:93131173–93131177. https://doi.org/10.1016/s0140-6736(02)08213-2

    Article  Google Scholar 

  37. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52:2262–2267. https://doi.org/10.1016/j.jaad.2004.06.017

    Article  Google Scholar 

  38. Sharma TS, Wasko MC, Tang X, Vedamurthy D, Yan X, Cote J et al (2016) Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients. J Am Heart Assoc 5:1. https://doi.org/10.1161/JAHA.115.002867

    Article  Google Scholar 

  39. Xie F, Yun H, Levitan EB, Muntner P, Curtis JR (2018) Tocilizumab and the risk for cardiovascular disease: a direct comparison among biologic disease-modifying antirheumatic drugs for rheumatoid arthritis patients. Arthritis Care Res. https://doi.org/10.1002/acr.23737

  40. Bili A, Tang X, Pranesh S, Bozaite R, Morris SJ, Antohe JL et al (2014) Tumor necrosis factor alpha inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis. Arthritis Care Res 66:3355–3363. https://doi.org/10.1002/acr.22166

    Article  CAS  Google Scholar 

  41. Barnabe C, Martin BJ, Ghali WA (2011) Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res 63:4522–4529. https://doi.org/10.1002/acr.20371

    Article  CAS  Google Scholar 

Download references

Contributors

FRX analyzed and interpreted the data and drafted the manuscript. LYF designed the study. FRX, TTW, HNL, YWX and MC collected the data. LYF contributed to the interpretation of the results and critical revision of the manuscript for important intellectual content and approved the final version of the manuscript. All authors have read and approved the final manuscript. FRX and LYF were the study guarantors.

Funding

This work was supported by grants from the Program of the National Natural Science Foundation of China (81673246).

Author information

Authors and Affiliations

  1. Department of Clinical Epidemiology and Evidence-based medicine, The First Affiliated Hospital of China Medical University, No.155, Nan Jing Bei Street, Shenyang, 110001, Liaoning Province, China

    Fangran Xin, Lingyu Fu, Tingting Wei & Meng Chen

  2. Department of Medical Record Management Center, The First Affiliated Hospital, China Medical University, Shenyang, China

    Lingyu Fu & Yunwei Xu

  3. Department of Rheumatology, The First Affiliated Hospital, China Medical University, Shenyang, China

    Haina Liu

Authors
  1. Fangran Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lingyu Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haina Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yunwei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tingting Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Meng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lingyu Fu.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 35 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xin, F., Fu, L., Liu, H. et al. Exploring metabolic and inflammatory abnormalities in rheumatoid arthritis patients developing stroke disease: a case-control study using electronic medical record data in northern China. Clin Rheumatol 38, 1401–1411 (2019). https://doi.org/10.1007/s10067-019-04440-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04440-5

Keywords

Search

Navigation